A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage - Wikidata - awgldk - TriplyDB

A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage

A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage

http://www.wikidata.org/entity/Q27677328

about

Elucidation of the binding preferences of peptide recognition modules: SH3 and PDZ domains Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS Endogenous IFN-β signaling exerts anti-inflammatory actions in experimentally induced focal cerebral ischemia Design and synthesis of high-affinity dimeric inhibitors targeting the interactions between gephyrin and inhibitory neurotransmitter receptors Molecular basis of the alternative recruitment of GABA(A) versus glycine receptors through gephyrin Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein family Accidental interaction between PDZ domains and diclofenac revealed by NMR-assisted virtual screening.IL1R9 Is Evolutionarily Related to IL18BP and May Function as an IL-18 Receptor.Reconstitution of multivalent PDZ domain binding to the scaffold protein PSD-95 reveals ternary-complex specificity of combinatorial inhibition Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species.Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via regulating group I metabotropic glutamate receptors.Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial.Progressive brain damage, synaptic reorganization and NMDA activation in a model of epileptogenic cortical dysplasia.Rigidified clicked dimeric ligands for studying the dynamics of the PDZ1-2 supramodule of PSD-95.Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus Ligand binding to the PDZ domains of postsynaptic density protein 95.Scaffolding protein Homer1a protects against NMDA-induced neuronal injury.Design and characterization of bivalent BET inhibitors.Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.Plasticity of PDZ domains in ligand recognition and signaling.Ligand binding by PDZ domains.The emerging contribution of sequence context to the specificity of protein interactions mediated by PDZ domains.Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases.Influence of GluN2 subunit identity on NMDA receptor function.Structures and target recognition modes of PDZ domains: recurring themes and emerging pictures.The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats.Posttranslational Modifications Regulate the Postsynaptic Localization of PSD-95.In vitro and in vivo effects of a novel dimeric inhibitor of PSD-95 on excitotoxicity and functional recovery after experimental traumatic brain injury.Organization and functions of mGlu and GABAB receptor complexes.Protein kinase A-phosphorylated KV1 channels in PSD95 signaling complex contribute to the resting membrane potential and diameter of cerebral arteries Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions.Novel drug target identification for the treatment of dementia using multi-relational association mining.Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia.NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage.Combining Graphical and Analytical Methods with Molecular Simulations To Analyze Time-Resolved FRET Measurements of Labeled Macromolecules Accurately Simultaneous prediction of binding free energy and specificity for PDZ domain-peptide interactions.Novel microscale approaches for easy, rapid determination of protein stability in academic and commercial settings.

P2860

Q27006986-5286730A-4A8E-4263-B692-F2A42C6F0C68 Q27021649-4672CC6B-9953-4B70-B0BC-9A6F2C9F62DD Q27303494-F7DB5171-43A9-4DD7-B635-EF34E0691F6F Q27696202-C76EC413-9687-4AB0-BD23-17A95CBC4FCD Q27696890-76963FB0-CDC0-46A4-BEFB-56DDDB172563 Q28543254-6ABF38D8-25A0-4F64-85E3-A471DDC107DA Q30353037-2D483375-3C59-48E1-A834-3BCE33099037 Q30395586-8E61A676-2789-4974-A072-FE71B797AD7A Q30591118-9C5FEEA3-8728-4C32-8E7A-A86D5B734BE2 Q31031847-9ADFD219-86C4-4455-8E74-3EB28E7BCCA1 Q33654169-CF9E8C29-53C0-4ADC-ADCF-F35C826A0C04 Q34451073-D5428752-DC97-42EA-A3A0-A8B8409A9DFF Q34655419-1575F4AB-C31C-4865-A3C9-649292F08495 Q35108304-F15C1BDC-D317-4F77-B74F-BE044D7218BB Q35434851-6696DA86-D1E1-4A23-9E6B-81FFD3A3E208 Q35583308-E2C9F7C6-D06A-44C0-86A8-C23F97695BFC Q35945639-05CD93F6-8BC6-4D3C-BC52-892F845A94F5 Q36022288-2E453E5F-90B9-4CB9-927E-551A3F41D937 Q36172939-8F779FF0-569A-4C2F-B9A4-5318F29DD6BC Q36809420-CA6E4D8F-DE80-4B8F-84B0-8A3AA64AB85A Q37189583-5771AEAD-AE9C-4FFF-B5E3-E81107DD3D20 Q38009191-1F1280C5-50DC-414D-8652-CEFAD5F1A751 Q38016834-85958A49-1E0E-4E0B-B057-859CDBDC1787 Q38019679-BFFEA329-CF47-4888-A740-7771D078B9FE Q38044699-0403CCFA-BB5D-4CE1-B70C-2CC4ADA25AF3 Q38078685-5A0B0BFB-3F6C-4431-9DB5-00EE96CD15F4 Q38136699-85599592-B1B0-4F24-9117-B4754D976CBF Q38213709-97ED15DD-9FA6-4766-82EB-DFDC26EC6A76 Q38638933-77D30C28-67E6-408D-87E3-88C2CC7FDC2A Q38736600-49FF59EC-3D82-4B2C-AE21-AAA19EE12C5D Q38793929-41488F48-940C-4094-85C0-69803CD0D622 Q39025392-D5A9A93B-0076-4C28-AD42-2AF777828552 Q40428610-B26B0310-E1DE-433F-B87E-6662129C0AE1 Q40733593-FE66F56D-BD43-4813-913E-B58819D12261 Q40758295-8BE2887F-C268-48B7-8D3D-FF4991B75FDE Q41022804-0E901C61-AA56-4300-BD21-A4B129939F82 Q41022884-B55E0C15-2D99-4E0F-AD83-18AC0BABD852 Q41411613-72C2806D-41C8-43F7-AB36-6781AC74A9FF Q41905100-EFB02523-1CB7-4BAB-B0C1-3698CBB37C47 Q43152204-42144C97-8924-4D5E-813E-71FDAA86DED0

P2860

A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage

http://www.wikidata.org/entity/Q27677328

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

A high-affinity, dimeric inhib ...... against ischemic brain damage

@ast

A high-affinity, dimeric inhib ...... against ischemic brain damage

@en

A high-affinity, dimeric inhib ...... against ischemic brain damage

@nl

type

label

A high-affinity, dimeric inhib ...... against ischemic brain damage

@ast

A high-affinity, dimeric inhib ...... against ischemic brain damage

@en

A high-affinity, dimeric inhib ...... against ischemic brain damage

@nl

prefLabel

A high-affinity, dimeric inhib ...... against ischemic brain damage

@ast

A high-affinity, dimeric inhib ...... against ischemic brain damage

@en

A high-affinity, dimeric inhib ...... against ischemic brain damage

@nl

P1433

Q27677328-F5F11387-B43F-4D9B-A045-F0E4E34602C1

P1476

Q27677328-14E3838B-8FE8-4DD4-A166-069140A812EE

P2093

Q27677328-1059931D-A2D1-4786-8B1A-545ED6BC2558

Q27677328-13D663A1-266F-45A8-B6E5-8F9E3DF0A135

Q27677328-4110958B-EDF7-43C7-94BB-85BEDE34F318

Q27677328-77914091-8568-41E3-9526-C6F106ACBE99

Q27677328-A803E3FE-2555-4F87-BD68-548B7877D5E3

P2860

Q27677328-05C6EB04-4408-40CB-9876-4889D3BC534A

Q27677328-307BAF3C-9D03-49A1-947C-8F29ABD2F46B

Q27677328-48A633EB-0488-4E15-AAE4-A5441D82793E

Q27677328-5089EFE5-EF2D-4C80-803D-90DACD33CC24

Q27677328-52D24460-F01E-416A-B29E-5B8616EC8785

Q27677328-554D498C-106D-48B1-92F6-7EE24852AAF1

Q27677328-713DCF42-5B6B-4BC1-A5F5-DBA62067E634

Q27677328-8114EC30-1EF8-4A9F-ACEB-1E5B7068D21C

Q27677328-84198FC8-6EC4-4DF3-9B5F-F2F973A0EE57

Q27677328-891E1B6B-74C9-4B3C-98E9-F319B0C93443

P304

Q27677328-B48420C3-42BB-4ED8-8986-8D68ED4C3D52

P31

Q27677328-4602B968-ACBF-4256-9C74-B6100993C5FD

P356

Q27677328-42BC1127-2765-4B5E-9423-72D48AD7EBE7

P407

Q27677328-17F734EE-0090-41DA-8D28-C06EFB4B7C52

P433

Q27677328-C1DDB6A3-B4AB-4422-A67E-6DC1FD076969

P478

Q27677328-C6046095-8EC7-4895-9EB9-02D6D5DB9641

P50

Q27677328-15E2123E-0F13-45AE-B386-0E0BB8DEE74D

Q27677328-3DE7961C-C042-40A2-9293-7FE862ABCED5

Q27677328-5A4AA272-50A5-447D-B133-A6F9958D7BD7

Q27677328-953101F0-4CA6-4234-B2C6-C8FACA20DFD4

Q27677328-A1CEA050-E60D-4928-B4B7-E0CCF06785F7

Q27677328-A8814010-3E25-4F93-8477-F93DC9545152

Q27677328-AACB6EEF-92A3-4AE4-A8B4-80AFB8CE1E83

Q27677328-CC1AE39A-3052-42C7-B446-80E2E162D468

Q27677328-E61C2D6F-618E-4406-8946-937042E1A964

Q27677328-FFAD17E3-2DEB-4959-B6E0-3427C4CC729C

P577

Q27677328-EC110C4D-F994-41F0-BB8F-8AF7B20E9DBD

P5875

Q27677328-8A2B9760-2D6F-4D2B-9FA8-E61D3F21905E

P698

Q27677328-A2DBADE6-B687-490A-9DB0-6E9B54EB9330

P921

Q27677328-3469B9A8-0116-4D04-85F5-E6ECF7692553

P932

Q27677328-0A1E06C6-02C3-467D-AE2F-B05359D43B93

P356

PNAS.1113761109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A high-affinity, dimeric inhib ...... against ischemic brain damage

@en

P2093

Celestine N Chi

http://www.w3.org/2001/XMLSchema#string

Klaus B Nissen

http://www.w3.org/2001/XMLSchema#string

Magda Møller

http://www.w3.org/2001/XMLSchema#string

Patrik Lundström

http://www.w3.org/2001/XMLSchema#string

Pernille L Sørensen

http://www.w3.org/2001/XMLSchema#string

P2860

Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein

Neuroprotection for ischemic stroke: past, present and future

Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95

Creating conformational entropy by increasing interdomain mobility in ligand binding regulation: a revisit to N-terminal tandem PDZ domains of PSD-95

Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization

Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

In vivo protein transduction: delivery of a biologically active protein into the mouse

Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand.

Deciphering the kinetic binding mechanism of dimeric ligands using a potent plasma-stable dimeric inhibitor of postsynaptic density protein-95 as an example.

P304

3317-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1113761109

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Michael Gajhede

Kristian Strømgaard

Bente Vestergaard

Kate Lykke Lambertsen

Anders S Kristensen

Bettina Hjelm Clausen

Jette S Kastrup

P577

2012-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221841077

http://www.w3.org/2001/XMLSchema#string

P698

22343531

http://www.w3.org/2001/XMLSchema#string

P921

P932

3295328

http://www.w3.org/2001/XMLSchema#string